During the past decade, Clinica CES conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica CES" #1 collaborator was "Baxter Healthcare Corporation" with 1 trials as a collaborator, "Clínica CES" with 1 trials as a collaborator and "Hospital Pablo Tobón Uribe" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Clinica CES" are "Acute Kidney Injury" (1 trials), "Anesthesia" (1 trials), "Covid19" (1 trials), "Septic Shock" (1 trials) and "Severe Acute Respiratory Syndrome" (1 trials). Many other conditions were trialed in "Clinica CES" in a lesser frequency.

Most popular intervention types in "Clinica CES" are "Device" (3 trials), "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Insulated Needle, (Stimuplex; Braun, Melsungen, Germany)" (1 trials), "Intravenous analgesics" (1 trials), "Ivermectin" (1 trials), "Levobupivacaine 0.5%: 20 ml" (1 trials) and "Midazolam" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica CES" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Clinica CES". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Clinica CES, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinica CES, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".